Case Studies
Pricing Strategy Development
Providing global recommendations for pricing and indication sequencing in oncologyPricing & market access recommendations for a product in alcohol dependence (EU and Russia)Development of a pricing & market access strategy in diabetes in Europe and the US
Evaluation of New Opportunities
Assessment of the price potential of an intranasal formulation of a benzodiazepine (EU5)Assessment of the P&MA potential of an in-licensing opportunity for a drug replacing surgery (Europe)Assessment of the value of a treatment for bladder cancer in ex-US markets
Value Proposition Development, Validation and Communication
Global Value Dossier development for a new product in ADHDInteractive Global Value Dossier development with external message testingValue Dossier for ‘re-launch’ of a hospital product in specific indications (US)
Evidence Gap Analysis and Planning
Evidence requirements and funding of a long-acting intravenous antibiotic in major European marketsAssessing the implications of different evidence packages for a new HIV drug (EU5, Russia & Mexico)Payer perspective on new data for an oncology product (US, UK, Italy, Germany and Brazil)
Payer Environment Assessment
Assessment to inform corporate strategy based on P&MA issues with biosimilarsPayer environment assessment and implications for global activity prioritisationAssessment of Future Payer Environment for Pipeline Products using a Payer Advisory Board
Payer Negotiation Training
European payer objection handling workshop for an orphan drug (enzyme replacement therapy)Payer negotiation simulation meeting for a new oral MS productSenior management workshop to aid integration of P&MA principles into development
Client Testimonials
Contact us
  • Address: The Old Sawmills, Filleigh EX32 0RN
  • United Kingdom
  • Email: info@rjwpartners.com
  • Telephone:
  • Ad Rietveld: +44 (0)7904 222 898
  • Neil Johnson: +44 (0)7904 225 978
  • Chloë Brown: +44 (0)7943 859 598